Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ginseng tonic pills
- Development stage
- Unknown
- Lead developer
- Tianjin Central Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ginseng Tonic Pills (人参补丸) is a traditional Chinese medicine (TCM) product developed and manufactured by Tianjin Central Pharmaceutical (a subsidiary of Tianjin Lisheng Pharmaceutical). Formulated as oral capsules, it contains a mixture of active botanical ingredients including ginseng, Cistanche deserticola, Radix Glehniae/Adenophorae, Fructus Corni, Radix Achyranthis Bidentatae, and Poria. It is traditionally used to nourish yin, tonify deficiency, nourish blood, calm the mind, and greatly replenish vital qi. It is indicated for congenital deficiency, qi and blood deficiency, physical fatigue, mental trance, dizziness, palpitations, forgetfulness, neurasthenia, and malnutrition.
- Brand names
- 松树
- Other names
- Renshenbu WanRenshenbuwan人参补丸
02
Targets
SFN (Protein kinase C inhibitor protein 1)HTR3A (5-hydroxytryptamine receptor 3A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)BACE1 (Beta-site APP-cleaving enzyme 1)EGFR (Epidermal growth factor receptor)IL-6 (Interleukin 6)IKs (Slowly activating delayed rectifier potassium channel (KCNQ1/KCNE1))MAPK3 (Mitogen-activated protein kinase 1)MMP9 (Matrix metalloproteinase-9)STAT3 (Signal Transducer and Activator of Transcription 3)TNFA (Tumor necrosis factor alpha (soluble))KCNH2 (Voltage-gated potassium channel subfamily H member 2)mTOR (Mammalian target of rapamycin kinase)
Beyond the preview
Go deeper on ginseng tonic pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ginseng tonic pills.